Login / Signup

The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia.

Yevgeniy A LinnikEdison W TsuiIsabella W MartinZbigniew M SzczepiorkowskiGregory Andrew DenommeJerome L GottschallJohn M HillNancy M Dunbar
Published in: Transfusion (2017)
This case describes the first reported concurrent DIIHA and DIIT due to TMP-SMX-induced antibodies in an HSCT patient. DIIHA and DIIT can present a diagnostic challenge in the setting of intermittent medication dosing.
Keyphrases
  • high glucose
  • diabetic rats
  • drug induced
  • locally advanced
  • squamous cell carcinoma
  • radiation therapy
  • endothelial cells
  • adverse drug